DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $331,000 | -11.3% | 1,324,202 | +8.3% | 0.00% | – |
| Q4 2021 | $373,000 | -35.0% | 1,223,102 | +8.7% | 0.00% | -100.0% |
| Q3 2021 | $574,000 | -42.8% | 1,125,502 | -18.2% | 0.00% | 0.0% |
| Q2 2021 | $1,004,000 | -40.0% | 1,375,579 | -24.6% | 0.00% | -50.0% |
| Q1 2021 | $1,674,000 | -25.7% | 1,824,839 | -35.6% | 0.00% | 0.0% |
| Q4 2020 | $2,252,000 | -10.5% | 2,832,739 | -5.2% | 0.00% | -33.3% |
| Q3 2020 | $2,516,000 | -18.0% | 2,988,552 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $3,068,000 | +476.7% | 3,146,752 | +87.4% | 0.00% | +200.0% |
| Q1 2020 | $532,000 | +52.4% | 1,679,187 | +121.4% | 0.00% | – |
| Q4 2019 | $349,000 | +123.7% | 758,292 | +797.7% | 0.00% | – |
| Q3 2019 | $156,000 | -45.5% | 84,472 | -15.9% | 0.00% | – |
| Q2 2019 | $286,000 | -28.7% | 100,477 | -7.0% | 0.00% | – |
| Q1 2019 | $401,000 | +289.3% | 108,070 | +108.5% | 0.00% | – |
| Q4 2018 | $103,000 | – | 51,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 269,544 | $213,000 | 0.35% |
| Southland Equity Partners LLC | 12,030 | $9,564 | 0.01% |
| Sugarloaf Wealth Management, LLC | 15,750 | $13,000 | 0.00% |
| Frontier Wealth Management LLC | 25,000 | $20,000 | 0.00% |
| Renaissance Technologies | 2,832,739 | $2,252,000 | 0.00% |
| UBS Group AG | 5,999 | $5,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Squarepoint Ops LLC | 17,984 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 106,341 | $85,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 29,477 | $24,000 | 0.00% |